ASO Author Reflections: Morbidity and Outcomes of Primary Tumor Management in Patients with Widely Metastatic Well-Differentiated Small Bowel Neuroendocrine Tumors

Ann Surg Oncol. 2024 Apr;31(4):2359-2360. doi: 10.1245/s10434-023-14823-3. Epub 2024 Jan 22.

Authors

Aradhya Nigam¹, Brian R Untch²

Affiliations

¹ Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. aradhya.nigam@medstar.net.
² Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

PMID: 38252266
DOI: 10.1245/s10434-023-14823-3

No abstract available

MeSH terms

Humans
Intestinal Neoplasms* / surgery
Morbidity
Neuroendocrine Tumors* / secondary
Neuroendocrine Tumors* / therapy
Pancreatic Neoplasms*
Stomach Neoplasms*

Supplementary concepts

Gastro-enteropancreatic neuroendocrine tumor